The role of oncogenic kras as a determinant of response to EGER?HER2 targeted therapies

The role of oncogenic kras as a determinant of response to EGER?HER2 targeted therapies

Bibliographic Details
Main Author:	Fenton, Audrey C.
Published:	Queen's University Belfast 2011
Subjects:	616.994
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.534743

Similar Items

Cellular fitness in response to oncogenic Kras
by: Caldwell, M. E.
Published: (2011)

Mouse models of melanoma driven by oncogenic KRAS
by: Milagre, Carla Sofia Curado
Published: (2010)

The role of her-targeted therapies on chemosensization in gastro-oesphageal cancer cells
by: Campbell, Lynn Rachel
Published: (2011)

Are Fibronectin and IGFB-3 determinants of EGFR/HER2 and its Therapeutic Targeting?
by: Dennison, Jose
Published: (2010)

The oncogenic role of PAX3 in neuroblastoma
by: Fang, Wen-Hui
Published: (2010)

The role of the oncogene SRC kinase in breast cancer development and metastasis
by: Wilson, Gavin John
Published: (2010)

The putative oncogene EEF1A2 and its role in breast and ovarian cancer
by: Tomlinson, Victoria
Published: (2007)

Components of the Ret oncogene signalling pathway
by: Buchanan, V. S.
Published: (1999)

Characterisation of the CD4+ T- cell response against oncogenic human papillomavirus from healthy volunteers
by: Gallagher, Kathleen
Published: (2006)

Characterisation of Novel Mutations in the K-Ras Oncogene
by: Bounds, Rebecca
Published: (2009)

Regulation of tumour growth and apoptosis by oncogenes and papillomaviruses
by: Arends, Mark J.
Published: (1992)

ZNF703 is a luminal-breast-cancer oncogene
by: Holland, D.
Published: (2011)

Tumour suppressors and oncogenes : Structure, function and drug design
by: Riedinger, Christiane
Published: (2008)

The Role of FKBPL in Steroid Hormone Receptor Signalling; Implications for Response to Endocrine Therapy
by: Byrne, C.
Published: (2010)

The role of inducible nitric oxide synthase and nitric oxide in tumour cells and their response to therapy
by: Fitzpatrick, Brian
Published: (2009)

Trafficking and signalling of oncogenic met
by: Joffre, Carine
Published: (2010)

Targeted therapies in endomental cancer - in vitro and in vivo models
by: Thangavelu, Amudha
Published: (2010)

Laboratory and clinical studies of the dual EGFR/HER2 tyrosine kinase inhibitor lapatinib in breast cancer
by: Leary, Alexandra
Published: (2011)

The identification of transcriptional targets of TBX2 and their role in breast cancer proliferation
by: Redmond, K. L.
Published: (2010)

Evaluation of MRS detectable metabolic markers of MEK1/" targeted therapies
by: Miniotis, Maria Falck
Published: (2010)

The role of hypoxia-regulated glucose transporters and glucose metabolism in the response to hypoxia-linked therapies and as an indicator of prognosis in solid tumours
by: Bates, Victoria
Published: (2010)

The response to the primary systemic therapy of breast cancer
by: Keen, Jeremy C.
Published: (1998)

Molecular markers of response to systemic therapy in prostate cancer
by: Scullin, P.
Published: (2008)

The role of endoglin in angiogenesis and its potential as an anti-angiogenic therapeutic target
by: Zhai, Zhenhua
Published: (2011)

Haemoxugenase in tumours and its role in vascular targetting with combretastatin A4 phosphate
by: Khelefi, Amel Feriel
Published: (2003)

Defining the clinical role of the mammalian target of rapamycin (mTOR) in lung cancer
by: Dhillon, Perminder Tony Singh
Published: (2010)

Assessment of angiogenesis as an early predictor of response to primary endocrine therapy in breast cancer
by: Marson, Lorna
Published: (1999)

A proteomic approach to identifying novel determinants of tumour response to chemotherapy in colorectal cancer
by: Wilson, P. M. D.
Published: (2008)

The use of functional imaging to access response during primary systemic therapy in operable breast cancer
by: Beresford, Mark
Published: (2006)

An assessment of the clinical utility of cirulating biomarkers of cell death to monitor response to therapy in patients with cancer
by: Greystoke, Alastair
Published: (2009)

Differential responsiveness of tumour necrosis factor receptors (TNFR) type 1 and 2 : the critical role of the TNFR stalk region
by: Richter, Christine
Published: (2011)

Preoperative systemic treatment of large operable primary breast carcinoma : relationship between tumour characteristics and response to therapy
by: Anderson, Elaine D. C.
Published: (1992)

Molecular targets in melanoma
by: Pearl, Robert Ashley
Published: (2008)

The DNA damage response : the role of mTOR pathway and the proteomic analysis of the ubiquitination process
by: Selvarajah, Jogitha
Published: (2011)

Role of KiRas4A isoform in aldosterone dependant responses in the renal epithelium
by: King, Sharon
Published: (2008)

Targeting angiogenesis in prostate cancer
by: Mavrou, Athina
Published: (2013)

Approaches to tumour vascular targeting
by: Modlich, Ute
Published: (2001)

The NG2 chondroitin sulphate proteoglycan : a possible target for malignant glioma?
by: Higgins, Samantha
Published: (2009)

The identification of novel therapeutic targets for the treatment of TBX2-driven breast cancers
by: D'Costa, Z. C.
Published: (2012)

Prostate cancer and targeted screening in BRCA1 and BRCA2 Mutation carriers
by: Mitra, Anita
Published: (2009)